Publications by authors named "Isabelle Treilleux"

Claim this Profile
C
Clinical and tumor features of patients with immune checkpoint inhibitor-related neurological disorders and anti-Yo antibodies.
Antonio Farina, Elise Peter, Nolwenn Billet, Macarena Villagrán-García, Véronique Rogemond, Isabelle Treilleux

Ther Adv Neurol Disord· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Relationship Between Ovarian Sertoli-Leydig Cell Tumors and Their Heterologous Elements: Emphasis on the Possible Prognostic Significance of TERT Pathogenic Variants.
Alexis Trecourt, Clémence Scard, Françoise Descotes, Jonathan Lopez, Isabelle Treilleux

Am J Surg Pathol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NUTM1/NUTM2B-Rearranged Intra-abdominal Sarcomas: A Distinct Entity From Sarcomas With ESR1 Overexpression as a Therapeutic Target.
Ziyad Alsugair, Marie Karanian, Alexandra Meurgey, Isabelle Treilleux, Caroline Renard

Mod Pathol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Optimal tissue quantity for molecular ancillary studies in multicenter clinical trials in gynecological oncology: Experience of the GINECO pathologists' group].
Alexis Trecourt, Guillaume Bataillon, Isabelle Treilleux, Corinne Jeanne, Christine Montoto-Grillot

Ann Pathol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-AK5 limbic encephalitis in a patient with pleural mesothelioma.
Giulia Sofia Cereda, Antonio Farina, Nolwenn Billet, Macarena Villagrán-García, Anne-Laurie Pinto, Isabelle Treilleux

J Neurol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Understanding biology to identify new therapeutic targets beyond chemotherapy in ovarian granulosa cell tumors].
Sil Endale Ahanda, Alexandra Lainé, Brunhilde Hanvic, Quentin Verdet, Léa Ikhlef, Isabelle Treilleux

Bull Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can Morphology and Immune Infiltration Predict the Homologous Recombination Deficiency Status in Newly Diagnosed High-Grade Serous Ovarian Carcinoma?: Lessons From the PAOLA-1/ENGOT-ov25 Trial, a GINECO Study.
Amel Kime, Guillaume Bataillon, Isabelle Treilleux, Céline Callens, Frédéric Selle

Arch Pathol Lab Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unraveling the Tumor Microenvironment and PD-L1 Expression across Tissue Types in High-Grade Serous Ovarian Cancer in the NeoPembrOV/GINECO Phase II Randomized Trial.
Laetitia Collet, Maude Ardin, David Venet, Justine Berthet, Sarah Ghamry-Barrin, Isabelle Treilleux

Clin Cancer Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HERV-derived epitopes represent new targets for T-cell-based immunotherapies in ovarian cancer.
Paola Bonaventura, Audrey Page, Olivier Tabone, Yann Estornes, Virginie Mutez, Isabelle Treilleux

J Immunother Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune landscape and TAM density in endometrial cancer: implications for immune checkpoint inhibitors efficacy.
Olivia Le Saux, Renaud Sabatier, Isabelle Treilleux, Léa-Isabelle Renaud, Pierre-Emmanuel Brachet

Ther Adv Med Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The MEF2D::NCOA2 Fusion Defines a Distinct Emerging Vulvovaginal Myxoid Epithelioid Tumor With Smooth Muscle Differentiation.
Alexis Trecourt, Guillaume Bataillon, François Le Loarer, Marie Donzel, Eudeline Alix, Isabelle Treilleux

Mod Pathol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broad versus limited gene panels to guide treatment in patients with advanced solid tumors: a randomized controlled trial.
Olivier Trédan, Damien Pouessel, Nicolas Penel, Sylvie Chabaud, Carlos Gomez-Roca, Isabelle Treilleux

Nat Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mucinous ovarian carcinoma: Impact of ovarian stimulation, hormonal contraception, and hormone replacement therapy.
Chloé Barbier de Reulle, Marine Rebotier, Nicolas Chopin, Léa Rossi, Isabelle Treilleux

Eur J Obstet Gynecol Reprod Biol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast Cancer Specificities of Patients With Anti-Ri Paraneoplastic Neurologic Syndromes.
Elise Peter, Isabelle Treilleux, Valentin Wucher, Macarena Villagrán-García, Pauline Dumez

Neurol Neuroimmunol Neuroinflamm· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Vulvar and Vaginal Adenocarcinomas of Intestinal Type Are Closer To Colorectal Adenocarcinomas Than To Carcinomas of Müllerian Origin.
Alexis Trecourt, Isabelle Treilleux, Daniel Pissaloux, Marie Donzel, Brice Thamphya

Mod Pathol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting benefit from PARP inhibitors using deep learning on H&E-stained ovarian cancer slides.
Frederik Marmé, Eva I Krieghoff-Henning, Lennard Kiehl, Christoph Wies, Jan Hauke, Isabelle Treilleux

Eur J Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A curious biphasic breast lesion].
Jérémy Schoelinck, Mellie Heinemann, Daniel Pissaloux, Tatiana Franceschi, Isabelle Treilleux

Ann Pathol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting ERK-MYD88 interaction leads to ERK dysregulation and immunogenic cancer cell death.
François Virard, Stéphane Giraud, Mélanie Bonnet, Léa Magadoux, Laetitia Martin, Isabelle Treilleux

Nat Commun· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant and adjuvant pembrolizumab in advanced high-grade serous carcinoma: the randomized phase II NeoPembrOV clinical trial.
Isabelle L Ray-Coquard, Aude-Marie Savoye, Camille Schiffler, Marie-Ange Mouret-Reynier, Olfa Derbel, Isabelle Treilleux

Nat Commun· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomic longitudinal profiling of the NeoPembrOv trial identifies drivers of immunoresistance in high-grade ovarian carcinoma.
Olivia Le Saux, Maude Ardin, Justine Berthet, Sarah Barrin, Morgane Bourhis, Isabelle Treilleux

Nat Commun· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaparib Addition to Maintenance Bevacizumab Therapy in Ovarian Carcinoma With BRCA-Like Genomic Aberrations.
Philip C Schouten, Sandra Schmidt, Kerstin Becker, Holger Thiele, Peter Nürnberg, Isabelle Treilleux

JAMA Netw Open· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane.
Hélène Vanacker, Isabelle Treilleux, Camille Schiffler, Ivan Bieche, Mario Campone

Br J Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCA1/2 alterations and reversion mutations in the area of PARP inhibitors in high grade ovarian cancer: state of the art and forthcoming challenges.
Laetitia Collet, Brunhilde Hanvic, Margherita Turinetto, Isabelle Treilleux, Nicolas Chopin

Front Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pan-TRK immunohistochemistry in gynaecological mesenchymal tumours: diagnostic implications and pitfalls.
Madalena Souto Moura, João Costa, Valérie Velasco, Felix Kommoss, Esther Oliva, Isabelle Treilleux

Histopathology· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers.
Aurélien Voissière, Carlos Gomez-Roca, Sylvie Chabaud, Céline Rodriguez, Axelle Nkodia, Isabelle Treilleux

Sci Transl Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis